Intracellular Na(+) concentration ([Na(+)](i)) rises in the heart during
ischemia, and on reperfusion, there is a transient rise followed by a return toward control. These changes in [Na(+)](i) contribute to ischemic and
reperfusion damage through their effects on Ca(2+) overload. Part of the rise of [Na(+)](i) during
ischemia may be caused by increased activity of the cardiac
Na(+)/H(+) exchanger (NHE1), activated by the ischemic rise in [H(+)](i). In support of this view, NHE1 inhibitors reduce the [Na(+)](i) rise during
ischemia. Another possibility is that the rise of [Na(+)](i) during
ischemia is caused by Na(+) influx through channels. We have reexamined these issues by use of two different NHE1 inhibitors,
amiloride, and
zoniporide, in addition to
tetrodotoxin (TTX), which blocks voltage-sensitive Na(+) channels. All three drugs produced cardioprotection after
ischemia, but
amiloride (100 microM) and TTX (300 nM) prevented the rise in [Na(+)](i) during
ischemia, whereas
zoniporide (100 nM) did not. Both
amiloride and
zoniporide prevented the rise of [Na(+)](i) on reperfusion, whereas TTX was without effect. In an attempt to explain these differences, we measured the ability of the three drugs to block Na(+) currents. At the concentrations used, TTX reduced the transient Na(+) current (I (Na)) by 11 +/- 2% while
amiloride and
zoniporide were without effect. In contrast, TTX largely eliminated the persistent Na(+) current (I (Na,P)) and
amiloride was equally effective, whereas
zoniporide had a substantially smaller effect reducing I (Na,P) to 41 +/- 8%. These results suggest that part of the effect of NHE1 inhibitors on the [Na(+)](i) during
ischemia is by blockade of I (Na,P). The fact that a low concentration of TTX eliminated the rise of [Na(+)](i) during
ischemia suggests that I (Na,P) is a major source of Na(+) influx in this model of
ischemia.